Active Ingredient History
Remimazolam, sold under the brand name Byfavo, is a medication for the induction and maintenance of procedural sedation in adults for invasive diagnostic or surgical procedures lasting 30 minutes or less. It is a benzodiazepine drug, developed by PAION AG in collaboration with several regional licensees as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in the induction of anesthesia and conscious sedation for minor invasive procedures. Remimazolam was found to have both a more rapid onset and a shorter duration than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Conscious Sedation (approved 2020)
Abortion, Induced (Phase 2)
Acne Vulgaris (Phase 4)
Adult (Phase 4)
Analgesia (Phase 3)
Anesthesia (Phase 4)
Anesthesia, General (Phase 4)
Anesthesia, Intravenous (Phase 3)
Anesthesia, Spinal (Phase 4)
Anesthetics (Phase 4)
Anesthetics, General (Phase 3)
Anesthetics, Intravenous (Phase 4)
Anxiety Disorders (Phase 4)
Arrhythmias, Cardiac (Phase 4)
Atrial Fibrillation (Phase 3)
Benzodiazepines (Phase 4)
Biological Availability (Phase 1)
Brachial Plexus Block (Phase 4)
Bronchiectasis (Phase 4)
Bronchoscopy (Phase 4)
Cognition (Phase 4)
Cognitive Dysfunction (Phase 4)
Colonoscopy (Phase 3)
Conscious Sedation (Phase 4)
Coronary Artery Disease (Phase 4)
COVID-19 (Phase 2)
Critical Illness (Phase 3)
Cryosurgery (Phase 4)
Deep Sedation (Phase 2)
Delirium (Phase 4)
Desflurane (Phase 4)
Dexmedetomidine (Phase 4)
Drugs, Investigational (Phase 4)
Emergence Delirium (Phase 4)
Endoscopy (Phase 2)
Esophageal and Gastric Varices (Phase 4)
Gastrectomy (Phase 4)
General Surgery (Phase 4)
Healthy Volunteers (Phase 3)
Hemodynamics (Phase 4)
Hemostasis, Endoscopic (Phase 4)
Hypnotics and Sedatives (Phase 4)
Intensive Care Units (Phase 4)
Intubation, Intratracheal (Phase 4)
Laparoscopy (Phase 4)
Leukemia, Lymphoid (Phase 2/Phase 3)
Liver Diseases (Phase 1)
Liver Failure (Phase 4)
Lung Diseases (Phase 2)
Midazolam (Phase 4)
Musculoskeletal Diseases (Phase 4)
Neoplasm Metastasis (Phase 4)
Neoplasms (Phase 4)
Obesity, Morbid (Phase 4)
Orthopedic Procedures (Phase 4)
Osteoarthritis, Knee (Phase 4)
Pain, Postoperative (Phase 3)
Perioperative Care (Phase 4)
Pharmacokinetics (Phase 4)
Pharmacology (Phase 4)
Postoperative Nausea and Vomiting (Phase 4)
Propofol (Phase 4)
Psychotropic Drugs (Phase 4)
Respiration, Artificial (Phase 4)
Respiratory Distress Syndrome (Phase 4)
Safety (Phase 4)
Sepsis (Phase 2)
Shock (Phase 2)
Stroke (Phase 2)
Substance-Related Disorders (Phase 1)
Tooth Extraction (Phase 3)
Unconsciousness (Phase 3)
Urinary Bladder Neoplasms (Phase 4)
Ventilation (Phase 2)
Wounds and Injuries (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
